Journal of Biological Chemistry · 2007 · 18 citations · 31 references
Life SciencesCell BiologyPharmacologyCell SignalingInflammationSignal TransductionApoptosis RegulationInflammatory SignalingReceptor RegulationNicotine Receptor SignalingP38 Mitogen-activated Protein Kinase SignalingTumor Necrosis Factor Receptor Signaling
A response by key neuronal nicotinic acetylcholine receptors (nAChRs) to sustained nicotine exposure is up-regulation. Although this unusual receptor characteristic contributes to processes ranging from aging to addiction, the normal physiologic reason for this response is unknown. We find that up-regulation of [3H]epibatidine binding and function in HEK293 cells stably expressing α4β2-nAChR is significantly enhanced by co-application of the proinflammatory cytokine, tumor necrosis factor α. The mechanism of tumor necrosis factor α-enhanced up-regulation requires transcription, new protein synthesis, and signaling through p38MAPK as demonstrated by complete inhibition using SB 202190. This finding extends the possibilities for nAChR-inflammatory interactions in normal physiological processes and offers novel insights into endogenous mechanisms that can modify up-regulation. A response by key neuronal nicotinic acetylcholine receptors (nAChRs) to sustained nicotine exposure is up-regulation. Although this unusual receptor characteristic contributes to processes ranging from aging to addiction, the normal physiologic reason for this response is unknown. We find that up-regulation of [3H]epibatidine binding and function in HEK293 cells stably expressing α4β2-nAChR is significantly enhanced by co-application of the proinflammatory cytokine, tumor necrosis factor α. The mechanism of tumor necrosis factor α-enhanced up-regulation requires transcription, new protein synthesis, and signaling through p38MAPK as demonstrated by complete inhibition using SB 202190. This finding extends the possibilities for nAChR-inflammatory interactions in normal physiological processes and offers novel insights into endogenous mechanisms that can modify up-regulation. Neuronal nicotinic acetylcholine receptors (nAChRs) 3The abbreviations used are:nAChRneuronal nicotinic acetylcholine receptor293HEK293EbepibatidineTNFαtumor necrosis factor αTNFRtumor necrosis factor receptorMAPKmitogen-activated protein kinaseMEKmitogen-activated protein kinase/extracellular signal-regulated kinase kinase. 3The abbreviations used are:nAChRneuronal nicotinic acetylcholine receptor293HEK293EbepibatidineTNFαtumor necrosis factor αTNFRtumor necrosis factor receptorMAPKmitogen-activated protein kinaseMEKmitogen-activated protein kinase/extracellular signal-regulated kinase kinase. play an important role in modulating normal neurotransmission in the central nervous system. These receptors also have a direct impact upon behavioral and physiological pathologies ranging from addiction to their early and selective loss in Alzheimer disease (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar). Addiction to nicotine correlates with the curious trait of up-regulation in response to chronic exposure to receptor ligands (2Schwartz R.D. Kellar K.J. J. Neurochem. 1985; 45: 427-433Crossref PubMed Scopus (249) Google Scholar, 3Marks M.J. Stitzel J.A. Collins A.C. J. Pharmacol. Exp. Ther. 1985; 235: 619-628PubMed Google Scholar, 4Benwell M.E. Balfour D.J. Anderson J.M. J. Neurochem. 1988; 50: 1243-1247Crossref PubMed Scopus (507) Google Scholar). The majority of high affinity nicotine receptors that undergo up-regulation in the mammalian brain are composed of at least nAChR α4 and β2 subunits as demonstrated by high affinity ligand binding and genetic studies (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar, 5Flores C.M. Rogers S.W. Pabreza L.A. Wolfe B.B. Kellar K.J. Mol. Pharmacol. 1992; 41: 31-37PubMed Google Scholar, 6Zoli M. Lena C. Picciotto M.R. Changeux J.P. J. Neurosci. 1998; 18: 4461-4472Crossref PubMed Google Scholar, 7Ross S.A. Wong J.Y. Clifford J.J. Kinsella A. Massalas J.S. Horne M.K. Scheffer I.E. Kola I. Waddington J.L. Berkovic S.F. Drago J. J. Neurosci. 2000; 20: 6431-6441Crossref PubMed Google Scholar). Although multiple mechanisms contribute to up-regulation (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar, 8Kishi M. Steinbach J.H. Mol. Pharmacol. 2006; 70: 2037-2044Crossref PubMed Scopus (20) Google Scholar, 9Vallejo Y.F. Buisson B. Bertrand D. Green W.N. J. Neurosci. 2005; 25: 5563-5572Crossref PubMed Scopus (168) Google Scholar), the normal physiological reason for this response is poorly understood despite its being conserved in animals ranging from Caenorhabditis to mammals. Since most of these organisms have never been exposed to nicotine either acutely or at any time throughout their evolutionary history, up-regulation probably reflects a normal physiological response preserved by processes of natural selection. It is also an intrinsic property of nAChRs composed of α4 + β2 subunits (termed α4β2-nAChR; see Refs. 10Lukas R.J. Changeux J.P. Le Novere N. Albuquerque E.X. Balfour D.J. Berg D.K. Bertrand D. Chiappinelli V.A. Clarke P.B. Collins A.C. Dani J.A. Grady S.R. Kellar K.J. Lindstrom J.M. Marks M.J. Quik M. Taylor P.W. Wonnacott S. Pharmacol. Rev. 1999; 51: 397-401PubMed Google Scholar and 11Wu J. Liu Q. Yu K. Hu J. Kuo Y.P. Segerberg M. St John P.A. Lukas R.J. J. Physiol. 2006; 576: 103-118Crossref PubMed Scopus (59) Google Scholar for additional nomenclature). Even when expressed in heterologous systems, such as human embryonic kidney cells, this receptor responds to nicotine with pharmacokinetics that are almost identical to those of the mammalian forebrain (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar, 12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar). neuronal nicotinic acetylcholine receptor HEK293 epibatidine tumor necrosis factor α tumor necrosis factor receptor mitogen-activated protein kinase mitogen-activated protein kinase/extracellular signal-regulated kinase kinase. neuronal nicotinic acetylcholine receptor HEK293 epibatidine tumor necrosis factor α tumor necrosis factor receptor mitogen-activated protein kinase mitogen-activated protein kinase/extracellular signal-regulated kinase kinase. Possible reasons for endogenous up-regulation of nAChR may involve the recent recognition of the participation by nicotinic receptors in regulating proinflammatory processes. In this context, α7-nAChR has received the greatest attention since its antagonism of the proinflammatory cytokine, TNFα, was documented over a decade ago (13Carlson N.G. Bacchi A. Rogers S.W. Gahring L.C. J. Neurobiol. 1998; 35: 29-36Crossref PubMed Scopus (93) Google Scholar). Subsequent investigations have supported the physiological relevance of this interaction in regulating numerous proinflammatory processes (14Wang H. Yu M. Ochani M. Amella C.A. Tanovic M. Susarla S. Li J.H. Yang H. Ulloa L. Al-Abed Y. Czura C.J. Tracey K.J. Nature. 2003; 421: 384-388Crossref PubMed Scopus (2350) Google Scholar). However, a more complex interaction between nAChRs and inflammation is suggested by studies using both tissue culture (13Carlson N.G. Bacchi A. Rogers S.W. Gahring L.C. J. Neurobiol. 1998; 35: 29-36Crossref PubMed Scopus (93) Google Scholar, 15Carlson N.G. Wieggel W.A. Chen J. Bacchi A. Rogers S.W. Gahring L.C. J. Immunol. 1999; 163: 3963-3968PubMed Google Scholar, 16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar) and animal models (14Wang H. Yu M. Ochani M. Amella C.A. Tanovic M. Susarla S. Li J.H. Yang H. Ulloa L. Al-Abed Y. Czura C.J. Tracey K.J. Nature. 2003; 421: 384-388Crossref PubMed Scopus (2350) Google Scholar, 17Orr-Urtreger A. Kedmi M. Rosner S. Karmeli F. Rachmilewitz D. Neuroreport. 2005; 16: 1123-1127Crossref PubMed Scopus (45) Google Scholar). For example, proinflammatory cytokines can impact upon nAChR expression through promoting efficient receptor assembly and altering relative subunit composition of mature nAChRs when HEK293 (293) cells are co-transfected with cDNA encoding α4 and β2 and/or β4, respectively (16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar). In these earlier studies, we did note a small but persistent increase of [3H]epibatidine ([3H]Eb) binding in 293 cells transiently expressing α4β2-nAChR that were also treated with TNFα (16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar). This has been examined further with 293 cells stably expressing nAChRs. Our findings show that the proinflammatory cytokine, TNFα, dramatically enhances α4β2-nAChR up-regulation induced by nAChR ligands, including nicotine, cytisine, and carbachol. The pathway to enhancement of up-regulation is both actinomycin D- and cycloheximidesensitive, and it is inhibited by SB 202190, a highly specific inhibitor of p38MAPK. These findings offer a novel insight into how proinflammatory cytokines can impact upon mechanisms of up-regulation and strongly suggest that reciprocal regulatory interactions between the nAChR and inflammatory systems are likely. Cell Lines and Culture Conditions—The 293 cell lines stably co-transfected with nAChR subunits α4 + β2, α4 + β4, α3 + β2, or α3 + β4, respectively, were generously provided by Drs. Ken Kellar and Yingxian Xiao (Department of Pharmacology, Georgetown University). These cells were maintained as described (12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar, 18Xiao Y. Meyer E.L. Thompson J.M. Surin A. Wroblewski J. Kellar K.J. Mol. Pharmacol. 1998; 54: 322-333Crossref PubMed Scopus (198) Google Scholar, 19Xiao Y. Kellar K.J. J. Pharmacol. Exp. Ther. 2004; 310: 98-107Crossref PubMed Scopus (136) Google Scholar). Additional analysis of these cells by real time PCR showed expression of RNA encoding the TNFR subtype 1 (cycle thresholds of 22) and the less abundant TNFR type 2 (cycle threshold of 35) compared with β-actin (cycle threshold of 17; not shown). Application of TNFα (human recombinant TNFα; BioSource) to these cells (25 ng/ml for 2–4 h) revealed that RNA encoding the inducible form of cyclooxygenase, COX2, was elevated 3-fold, demonstrating that TNFα stimulates cellular responses in these cells (not shown). The same assays revealed no evidence for the expression of the acetylcholine-synthesizing enzyme, choline acetyltransferase, or other human nAChR subunits (not shown). Radioligand Binding—The binding of [3H]Eb to cell membrane preparations was done essentially as described (12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar, 16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar), with the following modifications. Cells were distributed into 100-mm culture dishes and treated (e.g. with nicotine) 48 h later. Cells were harvested 18–24 h after treatment, at which time the cultures were 50–75% confluent, into 50 mm Tris buffer (pH 7.4, 4 °C), pelleted, resuspended, and homogenized. Cellular debris and nuclei were removed by low speed centrifugation (100 × g; 5 min), and the supernatant was collected and centrifuged (20,000 × g for 10 min) to pellet remaining membranes for ligand-binding assays. For binding assays, 5 μgof membrane was incubated with 5 nm [3H]Eb for 2–4 h at room temperature (∼25 °C). Nonspecific binding was assessed by adding 500 μm nicotine hydrogen tartrate (Sigma) for 30 min before the addition of [3H]Eb to block specific binding. Samples were tested in triplicate. Bound ligand was separated from free ligand by vacuum filtration through Whatman GF/C filters and prepared for scintillation counting. Specific binding was defined by averaging the total binding minus the nonspecific (nicotine-blocked) binding. Data were analyzed using Prism 3 (GraphPad Software Inc., San Diego, CA) as described (12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar, 18Xiao Y. Meyer E.L. Thompson J.M. Surin A. Wroblewski J. Kellar K.J. Mol. Pharmacol. 1998; 54: 322-333Crossref PubMed Scopus (198) Google Scholar, 19Xiao Y. Kellar K.J. J. Pharmacol. Exp. Ther. 2004; 310: 98-107Crossref PubMed Scopus (136) Google Scholar). Calcium Imaging—Fura-2/AM calcium imaging was done essentially as before (20Rogers S.W. Gregori N.Z. Carlson N. Gahring L.C. Noble M. Glia. 2001; 33: 306-313Crossref PubMed Scopus (77) Google Scholar). Cells were grown on glass coverslips coated with poly-l-lysine and laminin and washed four times with Hanks' solution (with 1.3 mm CaCl2 (Invitrogen)) over 20 min, and fresh buffer was 5 prepared in a the cells on coverslips were and fresh Hanks' buffer was before in a with the calcium system. 1 μm nicotine was the cells using a or a The cell response in the nm was was a and the was before adding 1 mm acetylcholine to receptors as a for cell in were prepared from multiple coverslips in which were for A cell was defined as a in the of the nm of from upon nicotine and that or a response to the were analyzed using The subunit composition of nAChRs their and response (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar). we examined how nicotine, TNFα, and the of these upon or respectively, stably expressed by 293 For these cells were treated for 18–24 h with nicotine TNFα (25 or both and specific binding of [3H]Eb to 5 of membrane protein was up-regulation of [3H]Eb binding to α3 + β2 and α4 + β2 over for and no for α3 + as (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar, 12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar). Although not as as nicotine, TNFα induced a small but increase in [3H]Eb binding by cells expressing α4β2-nAChR and but not or The most on ligand binding was in cells treated with TNFα and In these cells, the increase in [3H]Eb that of the and cells by A by TNFα on nicotine up-regulation was for receptors and to a but cells expressing a enhanced ligand binding relative to that was not We the the enhancement by TNFα on nicotine up-regulation of assays for up-regulation of [3H]Eb binding in response to 18–24 h of exposure to nicotine, TNFα, or nicotine TNFα were was in cells treated with as as nm nicotine and at 1 μm nicotine TNFα induced up-regulation at tested The of nicotine was at 1 μm and the of TNFα are in The enhancement of up-regulation relative to for nicotine in this at 1 μm nicotine and ng/ml TNFα, which was also in TNFα (25 and nicotine nm to 10 were done (not shown). The of addition including in were h in of the no on the (not shown). 1 μm nicotine and ng/ml TNFα were used in important in tissue culture is cell culture This is when such as cell and may also by ligands to the The of cell on of up-regulation was examined in cultures that were to of and respectively, following a total of h in culture and h after with nicotine, TNFα, or both as The show that cell cultures at the greatest enhancement by TNFα of up-regulation a in the of TNFα enhancement of up-regulation with cell This that cell culture the of TNFα to up-regulation. This finding is with cell nAChR expression by For culture was at the time of TNFα of RNA and mechanism of nicotine up-regulation was examined binding of [3H]Eb over a of for was For cells, the binding was and the was to a high affinity of as using Prism (12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar). from nicotine binding 500 show that at to × nicotine for of the specific [3H]Eb binding. was no in the affinity of this in these of 4 see 12Xiao Y. Baydyuk M. Wang H.P. Davis H.E. Kellar K.J. Bioorg. Med. Chem. Lett. 2004; 14: 1845-1848Crossref PubMed Scopus (36) Google Scholar) the these a nicotine and TNFα up-regulation by is to in receptor TNFα enhances up-regulation of α4β2-nAChR [3H]Eb binding was examined Although show up-regulation of nAChRs to of (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar), how TNFα enhancement of up-regulation is unknown. The cells were for TNFα to up-regulation. For this a membrane of cells was prepared as described for binding assays. of these preparations were treated with 1 μm nicotine, TNFα, or both nicotine and TNFα and incubated at for h with were collected by centrifugation and and were The show that of membranes with TNFα no on [3H]Eb a small but increase was in and those with nicotine This persistent increase is with of up-regulation through mechanisms that receptor affinity for ligand Y.F. Buisson B. Bertrand D. Green W.N. J. Neurosci. 2005; 25: 5563-5572Crossref PubMed Scopus (168) Google Scholar). the in ligand binding were the from cell and no TNFα enhancement of this up-regulation was that TNFα on up-regulation through mechanisms The time of up-regulation was examined to when up-regulation These were done as cells were harvested at times after the addition of nicotine and/or in a small enhancement by TNFα of nicotine up-regulation was with in 2 h of enhancement of up-regulation was not h This that the impact of TNFα on up-regulation is not to through of protein we examined the of the actinomycin on up-regulation. In these [3H]Eb binding of membranes from cells treated with nicotine, TNFα, nicotine TNFα, or for either in the or of 10 μm actinomycin by the not was the to the cells as in it was that with the was no by inhibition with actinomycin on the up-regulation of [3H]Eb binding treated with nicotine relative to However, TNFα enhancement of the up-regulation was In a inhibition of new protein with 10 μm was done as described for the actinomycin The of these in that essentially up-regulation as as TNFα enhancement of up-regulation relative to a small of up-regulation in cells treated with nicotine did to that in membrane However, we did not the that protein have is important is the of up-regulation and enhancement by TNFα relative to with the of actinomycin studies and the of the of enhanced these findings that the of TNFα enhancement of [3H]Eb binding requires both new and protein by by that nAChRs (e.g. nicotine) and (e.g. up-regulation M. J.P. Mol. Pharmacol. PubMed Scopus Google Scholar). In this context, to the of TNFα enhancement of the in [3H]Eb binding by cells in the or of TNFα for h and either 1 mm 10 μm 10 μm or a not to up-regulation of α4β2-nAChR [3H]Eb binding TNFα enhanced up-regulation induced by these to that with nicotine for no was The greatest up-regulation was with enhancement of this by TNFα was to that with other receptor is also an of the same was done in the of by no on [3H]Eb not shown). no on up-regulation of [3H]Eb binding or TNFα the of used was a was done to α4β2-nAChR up-regulation of and TNFα (25 enhanced this up-regulation. M. Steinbach J.H. Mol. Pharmacol. 2006; 70: 2037-2044Crossref PubMed Scopus (20) Google Scholar), the up-regulation of α4β2-nAChR by the was that of nicotine, TNFα also enhanced [3H]Eb binding these that in tested ligand binding by the nAChR the up-regulation enhancement by TNFα up-regulation is since this for calcium imaging This is nicotine up-regulation in receptors that are also and the of to function are In nAChR function is in cells min of (not shown). 18–24 h of 500 μm of 1 μm nicotine an in the in of the cells of cells for the which is in to cells that are to a response In cells treated with + TNFα, the response was on the response in cells, was a small increase in the of cells that was not in of This that TNFα, in addition to the of [3H]Eb also the of receptors their of but not the of cells to a of TNFα of α4β2-nAChR signaling through its receptors on numerous D.J. 14: PubMed Scopus Google Scholar, 2003; PubMed Scopus Google Scholar). to has been the of mitogen-activated protein kinase We have examined the of this pathway to enhancement of up-regulation using including those kinase signal-regulated and p38MAPK. For these with nicotine, TNFα, or both were done as described which is used as the for inhibitor has no on ligand binding. for these on the TNFα enhancement of up-regulation are in the TNFα enhancement of up-regulation. The of but the inhibitor A. C. K. J. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar), has no that signaling through at least the pathway is However, enhanced up-regulation was by the p38MAPK SB of these or inhibited up-regulation (not shown). has been with its to the expression of and this correlates with to addiction (1Hogg R.C. Raggenbass M. Bertrand D. Rev. Physiol. Biochem. Pharmacol. 2003; 147: 1-46Crossref PubMed Scopus (384) Google Scholar). this has also been to impact upon inflammatory and responses H. H. Ochani M. M. Yang L. Al-Abed Y. Wang H. C. Tracey K.J. Ulloa L. Med. 2004; PubMed Scopus Google Scholar). In a reciprocal inflammatory can the expression of nicotinic receptors (16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar). In this using stably cell we find that TNFα strongly enhances α4β2-nAChR of other inflammatory or nAChR through an actinomycin and p38MAPK signaling A these is in The p38MAPK has a central role in regulating and inflammatory responses as as physiological to cell cell and inhibition of up-regulation of α4β2-nAChR by the inhibitor but not the A. C. K. J. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar), participation of an additional pathway that to p38MAPK the in the of enhancement of the selective of this by both and and the role of p38MAPK in to suggest that enhancement of up-regulation through of a protein that nicotinic receptor expression by a are since these more efficient and/or from the to the cell the impact of these to upon subunit In enhancement of up-regulation is most in receptors the β2 However, we a small but and direct by TNFα on promoting ligand-binding for α4β2-nAChR and but not for This that the α4 subunit is also to that are by the TNFα enhancement up-regulation This and (13Carlson N.G. Bacchi A. Rogers S.W. Gahring L.C. J. Neurobiol. 1998; 35: 29-36Crossref PubMed Scopus (93) Google Scholar, H. Yu M. Ochani M. Amella C.A. Tanovic M. Susarla S. Li J.H. Yang H. Ulloa L. Al-Abed Y. Czura C.J. Tracey K.J. Nature. 2003; 421: 384-388Crossref PubMed Scopus (2350) Google Scholar, 15Carlson N.G. Wieggel W.A. Chen J. Bacchi A. Rogers S.W. Gahring L.C. J. Immunol. 1999; 163: 3963-3968PubMed Google Scholar, 16Gahring L.C. Days E.L. Kaasch T. Gonzalez de Mendoza M. Owen L. Persiyanov K. Rogers S.W. J. Neuroimmunol. 2005; 166: 88-101Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar) also that an interaction between inflammation and nAChR through multiple For example, α7-nAChR has been demonstrated to the of TNFα (14Wang H. Yu M. Ochani M. Amella C.A. Tanovic M. Susarla S. Li J.H. Yang H. Ulloa L. Al-Abed Y. Czura C.J. Tracey K.J. Nature. 2003; 421: 384-388Crossref PubMed Scopus (2350) Google Scholar), which inflammation inflammatory and the of α4β2-nAChR up-regulation. However, the between TNFα, and enhanced up-regulation of α4β2-nAChR may not since TNFα can from multiple that may or may not by A is to the relevance of this in the this is is to the that when are a to nicotine In this has been used as an of nicotine R.C. J. PubMed Scopus Google Scholar). is with elevated TNFα, in the of chronic nicotine enhanced up-regulation the and A in nicotinic receptor expression and inflammatory that is characteristic of aging is a and selective loss of α4β2-nAChR expression in the brain of both J. Neurochem. PubMed Scopus Google Scholar, S.W. Gahring L.C. Collins A.C. Marks M. J. Neurosci. 1998; 18: PubMed Google Scholar, Xiao Y. J.L. Kellar K.J. J. Neurochem. PubMed Scopus Google Scholar, L.C. Persiyanov K. Rogers S.W. Neurobiol. 2005; PubMed Scopus Google Scholar) and those with see Refs. K.J. K. PubMed Scopus Google Scholar and H. K. A. N. Y. PubMed Scopus Google Scholar). with the of and is also an increase in TNFα and other proinflammatory the between the loss of α4β2-nAChR expression and of is unknown. However, the of a interaction to this in both systems is These and other interactions between inflammatory cytokines and nAChR expression of the physiologic relevance of up-regulation as a normal to and of nAChR
31
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Hong Wang, Man Yu, Mahendar Ochani et al. · Nature · 2002 · 3.2K citations
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Hong Wang, Hong Liao, Mahendar Ochani et al. · Nature Medicine · 2004 · 1.2K citations